Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate
Clinical trial NCT00321763 · COMPLETED
Trial details
- NCT number
- NCT00321763
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-27
- Primary completion
- 2006-07-01
- Enrollment
- 3124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.